Comparative Pharmacology
Head-to-head clinical analysis: METHYLENE BLUE versus PROTOPAM CHLORIDE.
Head-to-head clinical analysis: METHYLENE BLUE versus PROTOPAM CHLORIDE.
METHYLENE BLUE vs PROTOPAM CHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methylene blue is a dye that acts as a redox agent, reducing methemoglobin to hemoglobin by activating the enzyme methemoglobin reductase. It also inhibits nitric oxide synthase and guanylate cyclase, causing vasoconstriction in septic shock.
Reactivates acetylcholinesterase inhibited by organophosphate poisoning by binding to the organophosphate moiety, forming a complex that undergoes hydrolysis to regenerate active enzyme. Also has a direct neutralization effect on certain organophosphates.
1-2 mg/kg IV over 5-30 minutes for methemoglobinemia; repeat after 1 hour if needed. Maximum dose: 7 mg/kg.
1-2 g IV over 15-30 minutes, may repeat after 1 hour if muscle weakness persists, then every 3-8 hours as needed for 24-48 hours.
None Documented
None Documented
Clinical Note
moderateMethylene blue + Torasemide
"Methylene blue may increase the hypotensive activities of Torasemide."
Clinical Note
moderateMethylene blue + Travoprost
"Methylene blue may increase the hypotensive activities of Travoprost."
Clinical Note
moderateMethylene blue + Unoprostone
"Methylene blue may increase the hypotensive activities of Unoprostone."
Clinical Note
moderateMethylene blue + Hydrochlorothiazide
Terminal elimination half-life approximately 12–24 hours; clinically, levels may persist for 2–3 days due to enterohepatic recycling
Terminal elimination half-life is approximately 1.7 hours in adults. In renal impairment, half-life may be prolonged up to 6 hours, requiring dose adjustment.
Renal (80% as leukomethylene blue and unchanged drug); biliary/fecal minor
Renal excretion is the primary route, with 80-90% of a dose eliminated unchanged in urine within 30 minutes; the remainder is metabolized and excreted fecally.
Category C
Category C
Antidote
Antidote
"Methylene blue may increase the hypotensive activities of Hydrochlorothiazide."